檢索結果 - Sohn, Joohyuk
- Showing 1 - 20 results of 39
- Go to Next Page
-
1
-
2
Talazoparib versus Chemotherapy in Patients with HER2-Negative Advanced Breast Cancer and a Germline BRCA1/2 Mutation Enrolled in Asian Countries: Exploratory Subgroup Analysis of... 由 Lee, Kyung-Hun, Sohn, Joohyuk, Goodwin, Annabel, Usari, Tiziana, Lanzalone, Silvana, Im, Seock-Ah, Kim, Sung-Bae
出版 2021Text -
3
-
4
-
5
-
6
Local Treatment in Addition to Endocrine Therapy in Hormone Receptor-Positive and HER2-Negative Oligometastatic Breast Cancer Patients: A Retrospective Multicenter Analysis 由 Cha, Chihwan, Ahn, Sung Gwe, Yoo, Tae-Kyung, Kim, Kun Min, Bae, Soong June, Yoon, Changik, Park, Soeun, Sohn, Joohyuk, Jeong, Joon
出版 2020Text -
7
Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs 由 Hata, Tomomi, Nakamura, Kenichi, Yonemori, Kan, Noguchi, Emi, Watanabe, Makiko, Sohn, Joohyuk, Lu, Yen‐Shen, Yap, Yoon‐Sim, Tamura, Kenji, Fujiwara, Yasuhiro
出版 2021Text -
8
-
9
A Phase II Study to Evaluate the Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients Receiving Dose-Dense Doxorubicin/Cyclophosphamide 由 Kim, Gun Min, Kim, Joo Hoon, Kim, Ji Heung, Cho, Young Up, Kim, Seung Il, Park, Seho, Park, Hyung Seok, Kim, Ji Ye, Sohn, Joohyuk
出版 2019Text -
10
Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups 由 Johnston, Stephen, O’Shaughnessy, Joyce, Martin, Miguel, Huober, Jens, Toi, Masakazu, Sohn, Joohyuk, André, Valérie A. M., Martin, Holly R., Hardebeck, Molly C., Goetz, Matthew P.
出版 2021Text -
11
-
12
Health‐Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor‐Positive, HER2‐Negative Advanced Breast Cancer After Endocrine Therapy 由 Kaufman, Peter A., Toi, Masakazu, Neven, Patrick, Sohn, Joohyuk, Grischke, Eva‐Maria, Andre, Valerie, Stoffregen, Clemens, Shekarriz, Sarah, Price, Gregory L., Carter, Gebra Cuyun, Sledge, George W.
出版 2019Text -
13
Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy 由 Kim, Chang Gon, Sohn, Joohyuk, Chon, Hongjae, Kim, Joo Hoon, Heo, Su Jin, Cho, Hyunsoo, Kim, In Jung, Kim, Seung Il, Park, Seho, Park, Hyung Seok, Kim, Gun Min
出版 2016Text -
14
Next-generation sequencing of BRCA1/2 in breast cancer patients: potential effects on clinical decision-making using rapid, high-accuracy genetic results 由 Park, Hyung Seok, Park, Seo-Jin, Kim, Jee Ye, Kim, Sanghwa, Ryu, Jaegyu, Sohn, Joohyuk, Park, Seho, Kim, Gun Min, Hwang, In Sik, Choi, Jong-Rak, Kim, Seung Il
出版 2017Text -
15
S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial 由 Moon, Yong Wha, Lee, Soohyeon, Park, Byeong-Woo, Kim, Eun-Kyung, Kim, Seung Il, Koo, Ja Seung, Park, Seho, Kim, Min Jung, Chung, Hyun Cheol, Kim, Joo-Hang, Sohn, Joohyuk
出版 2013Text -
16
Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer 由 Ahn, Sung Gwe, Lee, Jae-Hoon, Lee, Hak Woo, Jeon, Tae Joo, Ryu, Young Hoon, Kim, Kun Min, Sohn, Joohyuk, Yun, Mijin, Lee, Seung Ah, Jeong, Joon, Kim, Seung Il
出版 2017Text -
17
Anaplastic Lymphoma Kinase Gene Copy Number Gain in Inflammatory Breast Cancer (IBC): Prevalence, Clinicopathologic Features and Prognostic Implication 由 Kim, Min Hwan, Lee, Soohyeon, Koo, Ja Seung, Jung, Kyung Hae, Park, In Hae, Jeong, Joon, Kim, Seung Il, Park, Seho, Park, Hyung Seok, Park, Byeong-Woo, Kim, Joo-Hang, Sohn, Joohyuk
出版 2015Text -
18
Overexpression of Class III Beta Tubulin and Amplified HER2 Gene Predict Good Response to Paclitaxel and Trastuzumab Therapy 由 Jung, Minkyu, Koo, Ja Seung, Moon, Young Wha, Park, Byeong-Woo, Kim, Seung Il, Park, Seho, Lee, Soo Hyun, Hong, Soojung, Rha, Sun Young, Chung, Hyun Cheol, Kim, Joo Hang, Sohn, Joohyuk
出版 2012Text -
19
Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer 由 Bae, Soong June, Kim, Jee Hung, Ahn, Sung Gwe, Jeung, Hei-Cheul, Sohn, Joohyuk, Kim, Gun Min, Kim, Min Hwan, Kim, Seung Il, Park, Seho, Park, Hyung Seok, Kim, Ji Ye, Jeong, Joon
出版 2021Text -
20
The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer 由 Chae, Young Kwang, Gagliato, Debora de Melo, Pai, Sachin Gopalkrishna, Carneiro, Benedito, Mohindra, Nisha, Giles, Francis Joseph, Ramakrishnan-Geethakumari, Praveen, Sohn, Joohyuk, Liu, Shuying, Chen, Huiqin, Ueno, Naoto, Hortobagyi, Gabriel, Gonzalez-Angulo, Ana Maria
出版 2016Text